Literature DB >> 25400477

Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.

Letícia de Campos Franzoni1, Fábio Cardoso de Carvalho1, Rafael Gomes de Almeida Garzon1, Fábio da Silva Yamashiro1, Laís Augusti1, Lívia Alves Amaral Santos1, Mariana de Souza Dorna1, Júlio Pinheiro Baima1, Talles Bazeia Lima1, Carlos Antonio Caramori1, Giovanni Faria Silva1, Fernando Gomes Romeiro1.   

Abstract

UNLABELLED: Hepatic encephalopathy (HE) is a cognitive disturbance characterized by neuropsychiatric alterations. It occurs in acute and chronic hepatic disease and also in patients with portosystemic shunts. The presence of these portosystemic shunts allows the passage of nitrogenous substances from the intestines through systemic veins without liver depuration. Therefore, the embolization of these shunts has been performed to control HE manifestations, but the presence of portal vein thrombosis is considered a contraindication. In this presentation we show a cirrhotic patient with severe HE and portal vein thrombosis who was submitted to embolization of a large portosystemic shunt. CASE REPORT: a 57 years-old cirrhotic patient who had been hospitalized many times for persistent HE and hepatic coma, even without precipitant factors. She had a wide portosystemic shunt and also portal vein thrombosis. The abdominal angiography confirmed the splenorenal shunt and showed other shunts. The larger shunt was embolized through placement of microcoils, and the patient had no recurrence of overt HE. There was a little increase of esophageal and gastric varices, but no endoscopic treatment was needed. Since portosystemic shunts are frequent causes of recurrent HE in cirrhotic patients, portal vein thrombosis should be considered a relative contraindication to perform a shunt embolization. However, in particular cases with many shunts and severe HE, we found that one of these shunts can be safely embolized and this procedure can be sufficient to obtain a good HE recovery. In conclusion, we reported a case of persistent HE due to a wide portosystemic shunt associated with portal vein thrombosis. As the patient had other shunts, she was successfully treated by embolization of the larger shunt.

Entities:  

Keywords:  Liver cirrhosis; Port systemic shunt; Portal vein thrombosis; Recurrent hepatic encephalopathy; Shunt embolization

Mesh:

Year:  2014        PMID: 25400477      PMCID: PMC4229558          DOI: 10.3748/wjg.v20.i42.15910

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  [Chronic acquired hepatocerebral degeneration: the role of manganese and treatment by endovascular occlusion of a porto-systemic shunt].

Authors:  B Condat; A Dusoleil; M Bernardeau; A Roche; G Pelletier; C Buffet
Journal:  Gastroenterol Clin Biol       Date:  1999-02

2.  Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.

Authors:  María Gabriela Delgado; Susana Seijo; Ismael Yepes; Linette Achécar; Maria Vega Catalina; Angeles García-Criado; Juan G Abraldes; Joaquín de la Peña; Rafael Bañares; Agustín Albillos; Jaume Bosch; Juan Carlos García-Pagán
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

Review 3.  Management of hepatic encephalopathy in patients with cirrhosis.

Authors:  Gavin Wright; Rajiv Jalan
Journal:  Best Pract Res Clin Gastroenterol       Date:  2007       Impact factor: 3.043

4.  Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.

Authors:  Masafumi Kumamoto; Atsushi Toyonaga; Hiroto Inoue; Kenji Miyakoda; Yukihiko Morita; Keigo Emori; Yoshihiro Sakamoto; Kazuhiko Oho; Michio Sata
Journal:  J Gastroenterol Hepatol       Date:  2010-06       Impact factor: 4.029

Review 5.  Portal vein thrombosis in liver cirrhosis.

Authors:  Nao Kinjo; Hirofumi Kawanaka; Tomohiko Akahoshi; Yoshihiro Matsumoto; Masahiro Kamori; Yoshihiro Nagao; Naotaka Hashimoto; Hideo Uehara; Morimasa Tomikawa; Ken Shirabe; Yoshihiko Maehara
Journal:  World J Hepatol       Date:  2014-02-27

6.  Reversal of hepatic encephalopathy after occlusion of total portasystemic shunts.

Authors:  S S Hanna; R S Smith; J M Henderson; W J Millikan; W D Warren
Journal:  Am J Surg       Date:  1981-08       Impact factor: 2.565

7.  Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis.

Authors:  Xingshun Qi; Ming Bai; Zhiping Yang; Shanshan Yuan; Cheng Zhang; Guohong Han; Daiming Fan
Journal:  Med Hypotheses       Date:  2011-01-08       Impact factor: 1.538

8.  Embolization of the left portal vein to inferior vena cava shunts for chronic recurrent hepatic encephalopathy via the mesenteric vein.

Authors:  Y Takayama; S Moriura; J Nagata; A Akutagawa; A Hirano; S Ishiguro; T Matsumoto; T Sato
Journal:  J Gastroenterol Hepatol       Date:  2001-12       Impact factor: 4.029

9.  Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy.

Authors:  T Fukuda; S Hirota; K Sugimura
Journal:  J Vasc Interv Radiol       Date:  2001-03       Impact factor: 3.464

10.  Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.

Authors:  Beatriz Mínguez; Juan Carlos García-Pagán; Jaume Bosch; Juan Turnes; Juli Alonso; Alex Rovira; Juan Córdoba
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

View more
  3 in total

Review 1.  Hydrogel-Coated Coils: Product Description and Clinical Applications.

Authors:  Hector Ferral
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

Review 2.  Imaging and radiological interventions in extra-hepatic portal vein obstruction.

Authors:  Sudheer S Pargewar; Saloni N Desai; S Rajesh; Vaibhav P Singh; Ankur Arora; Amar Mukund
Journal:  World J Radiol       Date:  2016-06-28

3.  A novel, simplified, and reproducible porcine model of acute ischemic liver failure with portal vein preservation.

Authors:  Weisong Xue; Yu Fu; Haojie Zhang; Guoping Li; Peihua Cao; Yang Li; Qing Peng; Kebo Zhong; Shuangtang Feng; Yi Gao
Journal:  Exp Anim       Date:  2021-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.